首页> 外国专利> New somatostatin peptide derivs. - useful for inhibiting growth hormone, pancreatic and gastric secretion and for treating senile dementia

New somatostatin peptide derivs. - useful for inhibiting growth hormone, pancreatic and gastric secretion and for treating senile dementia

机译:新的生长抑素肽衍生。 -用于抑制生长激素,胰腺和胃分泌物以及治疗老年性痴呆

摘要

Polypeptides of formula (I) including salts and complexes are new: In (I) either (a) A = A1-W-A2-CO-N(A3)-CH(Z)-CO; W = CO-N(A4)- or -N(A5)-CO-; A1 and A4 each = H, (un)satd. hydrocarbyl or 7-10C phenylalkyl in which phenyl is opt. substd.; A5 = H or (un)satd. hydrocarbyl; or A1+A5 = tetra-or pentamethylene; A2 (un)satd. alkylene; A3 = an A4 gp.; N-CH(Z)-CO = (1) an (L)- or (D)- Phe residue opt. ring substd. or (2) the residue of a natural alpha-amino acid other than (1) or of a corresp. (D)-aminoacid; Z in N-CH(Z)-CO-represents the remainder of residue (1) or (2); A' = H; and Y1 and Y2 each = H or together represent a bond; or (b) A = H, alkyl, phenylalkyl or RCO; R = H, alkyl, phenyl or phenylalkyl; or RCO = (1), (2) or (3) a dipeptide residue in which the individual aminoacid residues are the same or different (1) or (2), the alpha-amino gp. of aminoacid residues (1) and (2) or the N-terminal amino gp. of dipeptide residues (3) opt. substd. by alkyl or 7-10C phenylalkyl and/or acyl; A' = H or when A is alkyl or phenylalkyl, then A' can also be 1-12C alkyl; Y1 and Y2 each = CO-CRaRb-(CH2)m-H, CO-NHRc, CO-NH-CHRd-COORe or a gp. of formula (4) or (5): Ra = Me or Et; Rb = H, Me or Et; m = 1-4; n = 1-5; Rc = 1-6C alkyl; Rd = the substit. attaching to the alpha-C of a neutral alpha-aminoacid (including H); R'a and R'b each = H, Me or Et; R8 and R9 = H, halo, 1-3C alkyl or 1-3C alkoxy; p = 0 or 1; q = 0 or 1; r = 0-2; and for both cases (a) and (b): B = Phe opt. ring-substd.; C' = (L)-Trp or (D) Trp, opt. alpha-N-methylated and opt. benzene-ring substd.; D = Lys opt. alpha-N-methylated; E = Thr, Ser or Val; F = COOR1, CH2OR2, CONR3R4 or gp. (6): R1 = H or 1-3C alkyl; R2 = H or the residue of hydrolysable ester; R3 = H, alkyl, phenyl or phenylalkyl; R4 = H, 1-3C alkyl or CH(R5)X; R5 = H, (CH2)2-OH or (CH2)3-OH or Rd; X = COOR1, CH2OR2 or CONR6R7; R6 = H or 1-3C alkyl; R7 = H, 1-3C alkyl, phenyl or 7-10C phenylalkyl. (50pp).
机译:式(I)的包括盐和配合物的多肽是新的:在(I)中,(a)A = A1-W-A2-CO-N(A3)-CH(Z)-CO; W = CO-N(A4)-或-N(A5)-CO-; A1和A4各自= H,(不)饱和。烃基或7-10C苯基烷基,其中苯基是优选的。 ; A5 = H或(未)饱和。烃基或A1 + A5 =四或五亚甲基; A2(未)星期六。亚烷基A3 = A4 gp。 N-CH(Z)-CO =(1)(L)-或(D)-Phe残基opt。环取代。 (2)(1)以外的天然α-氨基酸残基或相应残基。 (D)-氨基酸; N-CH(Z)-CO中的Z代表残基(1)或(2)的其余部分; A'= H; Y1和Y2各自= H或一起表示键; (b)A = H,烷基,苯基烷基或RCO;或R = H,烷基,苯基或苯基烷基;或RCO =(1),(2)或(3)二肽残基,其中各个氨基酸残基相同或不同(1)或(2),即α-氨基gp。 (1)和(2)氨基酸残基或N端氨基gp的残基。二肽残基的选择(3)。取代通过烷基或7-10C个苯基烷基和/或酰基; A'= H,或者当A是烷基或苯基烷基时,A'也可以是1-12C烷基; Y1和Y2各自= CO-CRaRb-(CH2)m-H,CO-NHRc,CO-NH-CHRd-COORe或gp。式(4)或(5)的通式:Ra = Me或Et; Rb = H,Me或Et; m = 1-4; n = 1-5; Rc = 1-6C烷基; Rd =替代。与中性α-氨基酸(包括H)的α-C相连; R'a和R'b分别为H,Me或Et; R8和R9 = H,卤素,1-3C烷基或1-3C烷氧基; p = 0或1; q = 0或1; r = 0-2;对于(a)和(b)两种情况:B = Phe opt。环取代的; C'=(L)-Trp或(D)Trp,选择α-N-甲基化并选择。苯环取代; D = Lys opt。 α-N-甲基化; E = Thr,Ser或Val; F = COOR1,CH2OR2,CONR3R4或gp。 (6):R 1 = H或1-3C烷基; R2 = H或可水解酯的残基; R3 = H,烷基,苯基或苯基烷基; R4 = H,1-3C烷基或CH(R5)X; R5 = H,(CH2)2-OH或(CH2)3-OH或Rd; X = COOR1,CH2OR2或CONR6R7; R6 = H或1-3C烷基; R7 = H,1-3C烷基,苯基或7-10C苯基烷基。 (50pp)。

著录项

  • 公开/公告号PT81783A

    专利类型

  • 公开/公告日1986-02-01

    原文格式PDF

  • 申请/专利权人 SANDOZ SA;

    申请/专利号PT19860081783

  • 发明设计人 RENE HUGUENIN;WILFRIED BAUER;JANOS PLESS;

    申请日1986-01-02

  • 分类号C07K7/26;

  • 国家 PT

  • 入库时间 2022-08-22 07:40:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号